| Trial Identifier: | PT003017 |
| Sponsor: | Pearl Therapeutics, Inc. |
| NCTID:: | NCT02685293 |
| Start Date: | December 2016 |
| Primary Completion Date: | June 2018 |
| Study Completion Date: | June 2018 |
| Condition: | Chronic Obstructive Pulmonary Disease (COPD) |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation |
| Country | Location |
|---|---|
| United States of America, AL | Birmingham, AL, United States of America, 35294 |
| United States of America, PA | Philadelphia, PA, United States of America, 19140 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company